(19)

(11)

EP 4 181 930 A1

(12)

(43) Date of publication: 24.05.2023 Bulletin 2023/21 (21) Application number: 21752805.8 (22) Date of filing: 15.07.2021

(51) International Patent Classification (IPC):  A61K 31/573(2006.01) A61P 27/02(2006.01) A61K 47/10(2017.01) A61P 27/04(2006.01) (52) Cooperative Patent Classification (CPC): A61K 9/0051; A61K 31/573; A61P 27/02; A61P 27/04; A61K 47/10 (86) International application number: PCT/US2021/041761 (87) International publication number: WO 2022/015940 (20.01.2022 Gazette 2022/03)

(84) Designated Contracting States: AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR Designated Extension States: BA ME Designated Validation States: KH MA MD TN (30) Priority: 16.07.2020 US 202063052646 P 11.12.2020 US 202063124176 P 29.04.2021 US 202163181720 P (71) Applicant: Ocular Therapeutix, Inc. Bedford, MA 01730 (US)	(72) Inventors: BLIZZARD, Charles, D. Nashua, NH 03064 (US) DESAI, Ankita Reading, MA 01867 (US) GOLDSTEIN, Michael Cambridge, MA 02138 (US) (74) Representative: Maiwald GmbH  Elisenhof Elisenstraße 3 80335 München 80335 München (DE)